Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Medartis

Explore full profile

Titanium implants and instruments for surgical osteosynthesis.

Basel, SwitzerlandFounded 1997Health Tech & Medtech
Valuation $1.12B Market cap · Aug/2026
Revenue $306M Latest reported FY
EBITDA $57M Latest reported FY

At a glance

Status
Listed
Founded
1997
Headquarters
Basel, Switzerland
Listing
IPO 2018
Sector
Health Tech & Medtech
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
21 countries with
team presence
🇨🇭 Switzerland34.7%
🇩🇪 Germany11.8%
🇧🇷 Brazil11.1%
🇺🇸 United States8%
🇫🇷 France6.6%
Top 5 of 21 shown

Patents

Estimated portfolio value
$33M

64 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Medartis was the backer or acquirer, 2017–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across Medartis's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Medartis deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Medartis's portfolio, mapped.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Medartis on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Medartis on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.